Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6354776 | 1.00 | CCR3 (0.58) | CCR3CYP2D6 | |
| SCHEMBL6354770 | 1.00 | CCR3 (0.58) | CCR3CYP2D6 | |
| SCHEMBL6983961 | 0.94 | CCR3 (0.55) | CCR3CYP2D6 | |
| SCHEMBL6355606 | 0.94 | CCR3 (0.55) | CCR3CYP2D6 | |
| SCHEMBL6355603 | 0.94 | CCR3 (0.55) | CCR3CYP2D6 | |
| SCHEMBL6344725 | 0.93 | CCR3 (0.60) | CCR3CYP2D6 | |
| SCHEMBL6344722 | 0.93 | CCR3 (0.60) | CCR3CYP2D6 | |
| SCHEMBL6347652 | 0.92 | CCR3 (0.62) | CCR3CYP2D6 | |
| SCHEMBL6347649 | 0.92 | CCR3 (0.62) | CCR3CYP2D6 | |
| SCHEMBL6348489 | 0.90 | CCR3 (0.61) | CCR3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1296978-A2 | N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2002002525-A2 | N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-01-10 | — | — | WO | claimed |
| EP-1296978-A2 | N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002002525-A2 | N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-01-10 | — | — | WO | disclosed |